The most advanced artificial heart has been approved for sale in European countries. A French firm is set to start selling this device in 2021’s second quarter. The device which is known as the Aeson is powered by batteries and depends on biological materials and sensors to detect the type of function it performs at any particular time.
The French firm, Carmat, has been trying to develop the Aeson for decades due to the increasing rates of heart disease in France and all over the world. According to estimates, heart disease claims 26 million lives annually.
The number of organ donors in Europe is not enough to meet the rising demands, and as such, the Aeson will be another alternative for people waiting for new hearts.
You can also read: Man Regains Sight After Receiving an Artificial Cornea
The idea behind this most advanced artificial heart, which was born nearly 30 years ago, was to create a device which would replace heart transplants, a device that works physiologically like a human heart, one that’s pulsating, self-regulated, and compatible with blood.Carmat CEO Stéphane Piat
The Aeson will work for several years in patients. This device works by adding biological bits to its mechanical ones, and utilizing actuator fluid and batteries to power the functions of a normal heart.
A man who had received the Aeson in 2015 said “I walk, I get up and I bend over 10 to 15 times a day, without any problem. I keep my balance. I’m not bothered. I don’t even think about it.”